Physical disabilities stem from disruptions along the neuro-musculoskeletal axis, involving the central nervous system (CNS), peripheral nervous system (PNS), or the muscular/skeletal systems directly.
1. Classification by Aetiology & Onset
Congenital & Developmental Conditions
Present at or before birth due to chromosomal abnormalities, intrauterine infections, genetic mutations, or perinatal asphyxia.
Cerebral Palsy (CP): Non-progressive encephalopathy caused by damage to the developing brain (often pre- or perinatal hypoxic-ischemic injury).
Clinical Example: Spastic Diplegia CP presents with hypertonia and spasticity predominantly in the lower extremities, causing a characteristic "scissoring" gait due to tight adductor muscles.
Spina Bifida: A neural tube defect resulting from incomplete closure of the embryonic neural tube (often associated with maternal folate deficiency).
Clinical Example: Myelomeningocele (the most severe form), where the spinal cord and meninges herniate through a spinal defect, leading to motor loss and sensory impairment below the lesion level, neurogenic bladder/bowel, and high risk for hydrocephalus.
Acquired Conditions
Occur postnatally following trauma, acute vascular events, or systemic illness.
Cerebrovascular Accident (CVA / Stroke): Acute focal neurological deficit resulting from vascular disruption (ischemic occlusion or hemorrhagic rupture).
Clinical Example: An ischemic stroke in the Left Middle Cerebral Artery (MCA) territory results in right-sided hemiplegia (paralysis of face/arm/leg), sensory loss, and expressive (Broca's) or receptive (Wernicke's) aphasia.
Traumatic Brain Injury (TBI) & Spinal Cord Injury (SCI): Damage caused by external mechanical forces.
Clinical Example: A C5 Complete Spinal Cord Injury causes tetraplegia (quadriplegia), preserving shoulder abduction (deltoid) and elbow flexion (biceps) but eliminating voluntary motor and sensory function below the C5 dermatome/myotome, requiring ventilatory support during early spinal shock.
Progressive Degenerative Diseases
Conditions characterized by ongoing, irreversible cell death or structural degeneration over time.
Muscular Dystrophies: Inherited disorders causing progressive muscle weakness and degeneration.
Clinical Example: Duchenne Muscular Dystrophy (DMD), an X-linked recessive disorder caused by a mutation in the dystrophin gene. Onset usually occurs in early childhood with proximal muscle weakness, demonstrated by Gowers' sign (using hands to "walk up" the legs to stand up from the floor), pseudohypertrophy of the calves, and eventual wheelchair dependence.
Multiple Sclerosis (MS): An autoimmune demyelinating disease of the CNS leading to axonal transection and plaque formation.
Clinical Example: A patient with Relapsing-Remitting MS (RRMS) presenting with optic neuritis (painful vision loss in one eye), subacute unilateral limb weakness, and Lhermitte's sign (an electric shock-like sensation running down the spine upon neck flexion).
2. Anatomical Localisation & Neurological Manifestations
┌─────────────────────────────────────────────────────────────┐
│ CENTRAL NERVOUS SYSTEM │
├──────────────────────┬──────────────────────┬───────────────┤
│ Cerebral Cortex │ Cerebellum │ Brain Stem │
│ (Upper Motor N.) │ (Coordination) │ (Vital Hub) │
└──────────┬───────────┴──────────┬───────────┴───────┬───────┘
│ │ │
▼ ▼ ▼
Paralysis & Ataxia & Dysmetria Autonomic &
Spasticity Cranial N.
│
└──────────────────────┬───────────────────┘
│
▼
┌─────────────────────────┐
│ Spinal Cord & PNS │
│ (Lower Motor Neurons) │
└────────────┬────────────┘
│
▼
Flaccid Paralysis &
Areflexia
Upper Motor Neuron (UMN) vs. Lower Motor Neuron (LMN) Lesions
Understanding the distinction between UMN (cortex, corticospinal tract) and LMN (anterior horn cells, peripheral nerves) is fundamental to localised physical assessment:
| Clinical Feature | Upper Motor Neuron (UMN) Lesion | Lower Motor Neuron (LMN) Lesion |
| Tone | Hypertonia (Clasp-knife rigidity, spasticity) | Hypotonia or Flaccidity |
| Deep Tendon Reflexes | Hyperreflexia (Clonus present) | Hyporeflexia or Areflexia |
| Planter Reflex | Positive Babinski sign (upward dorsiflexion) | Normal / Absent response |
| Atrophy | Minimal (disuse atrophy only) | Severe fasciculations & muscle wasting |
Neuroanatomical Structures & Pathophysiology
1. Cerebral Cortex (Motor System)
Structure: Primary Motor Cortex (Precentral Gyrus), Premotor Area, Supplementary Motor Area.
Pathophysiology: Disruption to upper motor neuron pathways reduces corticospinal output.
Key Terms:
Hemiparesis: Weakness affecting one side of the body.
Spasticity: Velocity-dependent increase in muscle tone resulting from loss of descending inhibitory control.
2. Cerebellum
Structure: Anterior/Posterior Lobes, Vermis, Cerebellar Peduncles.
Pathophysiology: Loss of real-time sensory feedback integration and motor correction, producing uncoordinated movements without true muscle weakness.
Key Terms:
Ataxia: Lack of voluntary coordination of muscle movements (e.g., broad-based gait).
Dysmetria: Inability to judge distance or scale of movement (over- or under-shooting targets on finger-to-nose testing).
Intention Tremor: Involuntary oscillatory movement that increases in amplitude as the limb approaches a target.
Dysdiadochokinesia: Inability to perform rapid alternating movements.
3. Brain Stem
Structure: Midbrain, Pons, Medulla Oblongata.
Pathophysiology: Interruption of ascending/descending tracts and cranial nerve nuclei (CN III–XII). Controls core autonomic homeostasis.
Key Terms:
Dysphagia: Impaired swallowing mechanism, creating severe risk for aspiration pneumonia.
Dysarthria: Motor speech disorder due to impaired muscular control of speech articulation.
Locked-In Syndrome: Basilar artery occlusion damaging the ventral pons, causing total paralysis of voluntary muscles except vertical eye movements, with fully preserved consciousness.
4. Spinal Cord & Peripheral Nerves
Structure: Anterior Horn Cells, Nerve Roots, Plexuses, Peripheral Axons/Myelin.
Pathophysiology: Interruption of LMN transmission or primary axonal destruction prevents signal arrival at the neuromuscular junction.
Key Terms:
Mononeuropathy / Polyneuropathy: Damage to a single nerve (e.g., Median nerve in Carpal Tunnel Syndrome) or diffuse symmetrical distal nerve damage (e.g., Diabetic Peripheral Neuropathy).
Neuropathic Pain: Burning or shooting pain caused by direct nerve lesioning (often featuring allodynia—pain from non-noxious stimuli).
5. Musculoskeletal System & Neuromuscular Junction
Structure: Myocytes, Sarcomeres, Neuromuscular Junction (NMJ), Synovial Joints.
Pathophysiology: Primary pathology in the muscle tissue itself, joint degeneration, or receptor blockades at the NMJ.
Key Terms:
Myasthenia Gravis: Autoimmune disorder targeting acetylcholine receptors at the NMJ, manifesting as fluctuating muscle fatigability (e.g., ptosis and diplopia that worsen as the day progresses).
Contractures: Permanent shortening of muscle tissue or fascia surrounding a joint, causing restricted Range of Motion (ROM).
1. Standardised Clinical Assessment Tools & Rating Scales
Evaluating physical disabilities requires validated clinical scales to objectify motor function, spasticity, and sensory deficits for baseline measurement and treatment planning.
A. ASIA Impairment Scale (AIS)
Published by the American Spinal Injury Association, the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) uses the AIS to classify the completeness and severity of a spinal cord injury.
Grade Classification Clinical Description A Complete No motor or sensory function is preserved in the sacral segments S4–S5. B Sensory Incomplete Sensory but not motor function is preserved below the neurological level and extends through the sacral segments S4–S5. C Motor Incomplete Motor function is preserved below the neurological level, and more than half of key muscles below the neurological level have a Muscle Grade less than 3 (on 0–5 manual muscle testing). D Motor Incomplete Motor function is preserved below the neurological level, and at least half of key muscles below the level have a Muscle Grade $\ge 3$. E Normal Motor and sensory functions are normal in all segments in an individual with prior deficits. B. Spasticity Assessment: Modified Ashworth Scale (MAS)
The MAS measures resistance during passive soft-tissue stretching to evaluate velocity-dependent muscle tone.
0: Normal muscle tone; no increase in tone.
1: Slight increase in tone, manifested by a catch and release or by minimal resistance at the end of the range of motion (ROM).
1+: Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainde
r (less than half) of the ROM. 2: More marked increase in muscle tone through most of the ROM, but affected part(s) easily moved.
3: Considerable increase in muscl
e tone; passive movement difficult. 4: Affected part(s)
rigid in flexion or extension.
C. Functional Mobility Assessment: Gross Motor Function Classification System (GMFCS)
Used primarily in pediatric neurology (e.g., Cerebral Palsy) to categorize functional movement capabilities across 5 distinct age bands.
[Level I] ──► Walks without restrictions; limitations in high-level gross motor skills [Level II] ─► Walks with limitations (outdoors and in community; difficulty on uneven terrain) [Level III] ─► Walks using hand-held mobility devices (canes, crutches, walkers) [Level IV] ─► Self-mobility with limitations; transported in manual/power wheelchair [Level V] ──► Severely limited motor control; dependent on manual wheelchair in all settings2. Pharmacological & Surgical Interventions
Management of severe physical disabilities—particularly upper motor neuron spasticity and joint contractures—requires combined medical and surgical strategies.
A. Pharmacological Management
┌─────────────────────────────────────────────────────────────┐ │ SPASTICITY PHARMACOTHERAPY │ ├──────────────────────────────┬──────────────────────────────┤ │ Systemic Agents │ Focal Injections │ │ (Broad Hypertonia Impact) │ (Isolated Muscle Groups) │ └──────────────┬───────────────┴──────────────┬───────────────┘ │ │ ▼ ▼ Central Inhibition Peripheral Blockade (Baclofen, Tizanidine) (Botulinum Toxin)Systemic Pharmacotherapy
Used when spasticity is generalised across multiple body segments.
Baclofen (GABAB Receptor Agonist):
Mechanism: Binds to presynaptic GABAB receptors in the spinal cord, reducing monosynaptic and polysynaptic reflex transmission by inhibiting calcium influx.
Route: Oral or Intrathecal Baclofen (ITB) Pump (surgical implantation of a pump in the abdominal wall delivering micro-doses directly into the subarachnoid space, bypassing systemic side effects like sedation).
Tizanidine ($\alpha_2$-Adrenergic Receptor Agonist):
Mechanism: Increases presynaptic inhibition of motor neurons at the spinal level, reducing muscle tone with less direct loss of muscle strength than central muscle relaxants.
Dantrolene Sodium (Direct-Acting Peripheral Muscle Relaxant):
Mechanism: Inhibits calcium release from the sarcoplasmic reticulum via the ryanodine receptor (RyR1), directly uncoupling the excitation-contraction mechanism in skeletal muscle.
Focal Pharmacotherapy
Targeted interventions when spasticity is localised to specific agonist muscle groups (e.g., focal hand or foot spasticity).
Botulinum Toxin Type A (Botox / Dysport / Xeomin):
Mechanism: Cleaves the SNAP-25 protein, inhibiting the presynaptic release of Acetylcholine (ACh) at the neuromuscular junction.
Clinical Application: Injected directly into spastic muscles (e.g., gastrocnemius to correct equine gait, or flexor digitorum profundus for tightly clenched fists). Effects onset in 3–7 days and last 3–4 months.
B. Surgical Interventions
When pharmacotherapy and physical therapy fail to maintain functional alignment or prevent severe deformities, surgical correction becomes necessary.
1. Neurosurgical Interventions
Selective Dorsal Rhizotomy (SDR):
Indication: Severe spastic diplegia in cerebral palsy.
Procedure: Laminectomy at the L2–S1 level exposes spinal rootlets. Individual sensory (dorsal) rootlets are electromyographically tested; those causing abnormal reflex circuits are selectively severed. This permanently eliminates spasticity while preserving motor function.
2. Orthopaedic Surgical Interventions
Tendon Lengthening & Tenotomy:
Indication: Fixed contractures limiting joint Range of Motion.
Example: Percutaneous Achilles Tendon Lengthening (TAL) to relieve equinus deformity and allow flat foot strike during stance phase.
Tendon Transfers:
Indication: Balancing muscle forces around a joint when specific muscle groups are permanently paralysed while adjacent ones remain under voluntary control.
Example: Transferring the Splenius Capitis or Extensor Carpi Radialis Longus (ECRL) to restore thumb opposition or hand opening in cervical spinal cord injury.
Osteotomy & Arthrodesis:
Indication: Structural bone misalignment or painful, unstable joints.
Example: Derotational Femoral Osteotomy to correct severe internal hip rotation, or triple arthrodesis of the foot to stabilise a severely deformed ankle.
No comments:
Post a Comment